Cargando...
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial
IMPORTANCE: Several surrogates for prostate cancer–specific mortality satisfying the Prentice criteria exist, but whether these are surrogates for all-cause mortality, and how their performance compares, is unknown. OBJECTIVE: To ascertain and compare the performance of 4 candidate surrogates (prost...
Gardado en:
| Publicado en: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Medical Association
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5470391/ https://ncbi.nlm.nih.gov/pubmed/28097317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.5983 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|